In older mice, stem cell-derived vesicles delivered through the nose reduce harmful oxidative damage in the brain and improve the function of energy-producing mitochondria in brain cells.
Claim Context
In aged mice, intranasal hiPSC-NSC-EVs reduce oxidative stress in the hippocampus by increasing NRF2 and superoxide dismutase levels while decreasing malondialdehyde and protein carbonyls, which correlates with enhanced expression of mitochondrial respiratory chain genes.
“Compared to the aged-Veh group, both males and females in the aged-EVs group displayed reduced concentrations of MDA and PCs (p < 0.01–0.0001), increased concentrations of NRF-2 and SOD (p < 0.01), and significantly increased expression of many mitochondrial respiratory chain genes.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether intranasal hiPSC-NSC-EVs consistently reduce hippocampal oxidative stress and enhance mitochondrial gene expression across diverse aging models and dosing regimens.
A systematic review and meta-analysis of all published RCTs in aged rodents (≥18 months) using intranasal hiPSC-NSC-EVs, measuring hippocampal MDA, protein carbonyls, NRF2, SOD, and expression of Complex I–V genes as primary outcomes, with subgroup analyses by sex, dose, and treatment duration.
That intranasal hiPSC-NSC-EVs directly cause reduction in oxidative stress and improvement in mitochondrial gene expression in aged mice.
A double-blind RCT in 60 aged C57BL/6 mice (18 months), randomized to intranasal hiPSC-NSC-EVs (12×10⁹ EVs, two doses) or vehicle, with primary outcomes being hippocampal MDA, protein carbonyls, NRF2, SOD, and mRNA levels of Ndufs6, Sdha, Cox4i2, and Atp6ap1 measured at 20.5 months.
Whether the degree of oxidative stress reduction predicts long-term cognitive preservation in aged mice treated with hiPSC-NSC-EVs.
A longitudinal cohort study following 100 aged C57BL/6 mice from 18 to 24 months, with 50 receiving intranasal hiPSC-NSC-EVs and 50 receiving vehicle, measuring hippocampal oxidative stress markers and mitochondrial gene expression every 2 months and correlating with cognitive decline trajectories.
Whether mice with the highest baseline oxidative stress show the greatest response to hiPSC-NSC-EVs treatment in terms of mitochondrial gene upregulation.
A case-control study comparing aged C57BL/6 mice with high baseline hippocampal MDA (cases) to those with low MDA (controls), matched for age and sex, to determine if hiPSC-NSC-EVs treatment increases mitochondrial gene expression more in high-oxidative-stress cases.
Whether there is a correlation between intranasal EV uptake in microglia and the degree of oxidative stress reduction in aged mice.
A cross-sectional analysis of 60 aged C57BL/6 mice at 20.5 months, measuring PKH-26-labeled EV uptake in microglia via fluorescence and correlating it with hippocampal MDA, NRF2, and mitochondrial gene expression levels.